Contributing to Global Animal Health
I had the opportunity to speak at the 29th AVC General Assembly held in Utrecht, the Netherlands, about the issue of shortages of veterinary medicines, which has emerged as a post-COVID issue.
It was a very meaningful opportunity to discuss the issue not only with consultants from each country, but also with Dr. Schalansky of the EU (European Community) EMA (European Medicines Agency).
Would you like to grow your companion animal business outside the US but are not sure where and now? How about in one of the most valuable markets in the world, Japan? Brakke Consulting can help.
For the first time, Brakke Consulting will be presenting a seminar on taking the first step in Japan at the Western Veterinary Conference on Monday, February 19th from 9:30-10:30 am in the Acacia 1 room at the Four Seasons Hotel. This seminar will be presented by Yuki Ujimasa, DVM, MS, a Brakke senior consultant based in Tokyo, who has broad experience in the Japanese market. Yuki will focus on the steps needed to get your product approved by the regulatory authorities in Japan. This will be a great seminar for companies looking to expand their global business but need some help to get started.
Monday, February 19, 2024 at WVC
Four Seasons Hotel, Acacia Room
Dr. Yuki Ujimasa, DVM, MS gave the captioned presentation to veterinary practitioners and veterinary nurses at the 29th Hokkaido Small Animal Veterinary Association on November 5th.
The above event was successfully held on October 17 and 18 in Tokyo.
AHRMS, Inc. played a role as Consulting Partner and Dr. Yuki Ujimasa, DVM, MS, President of the company, hosted a panel discussion titled “The key trends and dynamics of companion animal veterinary practices in Japan” with 4 Japanese panelists.
Brakke Consulting will present a special edition of its highly regarded Animal Health Industry Overview specifically for Japan on June 7th. The presentation will be both in English and Japanese.
“The 2023 Brakke Industry Overview – Japan” の続きを読むThe Ministry of Agriculture, Forestry and Fisheries has notified prefectural governments and the Japan Veterinary Medical Association of standards for appropriately conducting clinical research on veterinary drugs that do not violate the Pharmaceutical Affairs Law.
“Clinical research on animal pharmaceuticals, first rule setting by the government” の続きを読むThe mVm, modern veterinary medicine, is a Japanese commercial veterinary magazine.
This issue’s special feature is “Exit Strategy for Animal Hospitals”, and Dr. Yuki Ujimasa, DVM, MS., our representative, spent a year working with the editorial group of the publishing company since last spring, and was honored to write the foreword.
We attended the 95th WVC held in Las Vegas on February 19-22.
This visit was the first time in 3 years due to COVID-19 pandemic.
This is the second time I have spoken at a seminar held by the Okayama Veterinary Medical Association, and the last time was in July 2015.
At that time, I talked about various changes in the external and internal environments under the title of “Environmental changes approaching veterinary clinics in Japan.”
This time, I talked about the following six themes after verifying how much the “changes” introduced last time actually had an impact to the veterinary industry.
I received many questions. Thank you very much.
Dr. Ujimasa of AHRMS gave presentations regarding “the current situation and challenges of the Japanese veterinary medicine market” to over 450 certified veterinary medicine sales persons in Sapporo, Tokyo, and Nagoya in 2022.
